• We apologize for the intermittent downtime on the site as we work through some technical difficulties.

Inovio, with path to market opening up, drafts accelerated approval talking points ahead of...

cafead

Administrator
Staff member
  • cafead   Nov 10, 2023 at 10:22: AM
via Inovio Pharmaceuticals has a line of sight on an accelerated approval. Weeks after getting the green light to use data from a completed single-arm phase 1/2 clinical trial to support a filing, the DNA medicine specialist has set out what the opening up of the regulatory pathway means for its rare disease drug.

article source